Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

September 13, 2019

Study Completion Date

July 15, 2020

Conditions
Moderate to Severe Chronic Plaque-type Psoriasis
Interventions
DRUG

secukinumab 150 mg

sub-cutaneous secukinumab prefilled syringe 150 mg

Trial Locations (67)

4032

Novartis Investigative Site, Debrecen

7623

Novartis Investigative Site, Pécs

11000

Novartis Investigative Site, Prague

11375

Novartis Investigative Site, Forest Hills

20089

Novartis Investigative Site, Rozzano

20246

Novartis Investigative Site, Hamburg

20537

Novartis Investigative Site, Hamburg

23507

Novartis Investigative Site, Norfolk

24105

Novartis Investigative Site, Kiel

27157

Novartis Investigative Site, Winston-Salem

28277

Novartis Investigative Site, Charlotte

29414

Novartis Investigative Site, Charleston

30022

Novartis Investigative Site, Alpharetta

30078

Novartis Investigative Site, Snellville

33409

Novartis Investigative Site, West Palm Beach

33612

Novartis Investigative Site, Tampa

35205

Novartis Investigative Site, Birmingham

40241

Novartis Investigative Site, Louisville

41124

Novartis Investigative Site, Modena

42303

Novartis Investigative Site, Owensboro

44793

Novartis Investigative Site, Bochum

45324

Novartis Investigative Site, Fairborn

46256

Novartis Investigative Site, Indianapolis

47150

Novartis Investigative Site, New Albany

53100

Novartis Investigative Site, Siena

53717

Novartis Investigative Site, Madison

55112

Novartis Investigative Site, New Brighton

60077

Novartis Investigative Site, Skokie

60590

Novartis Investigative Site, Frankfurt

64506

Novartis Investigative Site, Saint Joseph

72758

Novartis Investigative Site, Rogers

75150

Novartis Investigative Site, Mesquite

77056

Novartis Investigative Site, Houston

78218

Novartis Investigative Site, San Antonio

78660

Novartis Investigative Site, Pflugerville

80111

Novartis Investigative Site, Centennial

80138

Novartis Investigative Site, Napoli

85032

Novartis Investigative Site, Phoenix

90404

Novartis Investigative Site, Santa Monica

92123

Novartis Investigative Site, San Diego

92697

Novartis Investigative Site, Irvine

95817

Novartis Investigative Site, Sacramento

95819

Novartis Investigative Site, Sacramento

97045

Novartis Investigative Site, Oregon City

97210

Novartis Investigative Site, Portland

98801

Novartis Investigative Site, Wenatchee

197022

Novartis Investigative Site, Saint Petersburg

350020

Novartis Investigative Site, Krasnodar

398005

Novartis Investigative Site, Lipetsk

410012

Novartis Investigative Site, Saratov

420012

Novartis Investigative Site, Kazan'

454092

Novartis Investigative Site, Chelyabinsk

620023

Novartis Investigative Site, Yekaterinburg

02111

Novartis Investigative Site, Boston

08520

Novartis Investigative Site, East Windsor

07044

Novartis Investigative Site, Verona

10025 1737

Novartis Investigative Site, New York

T2G 1B1

Novartis Investigative Site, Calgary

T4N 6V7

Novartis Investigative Site, Red Deer

M8X 1Y9

Novartis Investigative Site, Etobicoke

N1L 0B7

Novartis Investigative Site, Guelph

L8N 1V6

Novartis Investigative Site, Hamilton

G1V 4X7

Novartis Investigative Site, Québec

741 01

Novartis Investigative Site, Nový Jičín

04103

Novartis Investigative Site, Leipzig

H 6725

Novartis Investigative Site, Szeged

06100

Novartis Investigative Site, Perugia

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY